– BELGIUM, Gent – FEops today announced the appointment of Dr. Euan Thomson (Ph.D.) as the new Chairman of the Board of Directors, succeeding Rob Michiels who remains on the Board as an independent director.
“I am grateful for the trust of the entire FEops team and its investors, and I’m looking forward to what we will achieve together. With what I have seen from FEops so far, I genuinely believe in the potential of FEops and truly look forward to expanding together in new areas” said Dr. Euan Thomson.
“With Rob Michiels and Euan Thomson as independent board members and non-executive chairman in the FEops board, we combine a wealth of experience in the structural heart and the digital health industry. We feel privileged that both have chosen to support FEops in its plan to alter the course of structural heart and other diseases with our game-changing predictive digital twin technology“ said CEO and co-founder, Dr, Matthieu De Beule.
About FEops
Privately held FEops, headquartered in Gent, Belgium, is a digital health scale-up altering the course of heart disease by providing physicians with unique digital tools to treat the right patients with the right technology at the right time. FEops is supported by Valiance Advisors, Capricorn partners, PMV, and the EIC Fund.
For more information: https://www.feops.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
